10/02/2026 | Press release | Distributed by Public on 10/02/2026 16:04
|
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
|
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Deferred Stock Units | (1) | 09/30/2026 | A | 2,469 | (1) | (1) | Common Stock | 2,469 | $17.72 | 5,225 | D | ||||
| Dividend Equivalent DSUs(2) | (2) | (2) | (2) | Common Stock | 19.4313(2) | 19.4313(2) | D | ||||||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Groothuis Leo Frans 1000 MYLAN BOULEVARD CANONSBURG, PA 15317 |
X | |||
| /s/ Kevin Macikowski, by power of attorney | 10/02/2026 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | On September 30, 2026, the reporting person was automatically granted 2,469 deferred stock units (DSUs) pursuant to the reporting person's election to receive payment of quarterly non-employee director fees in the form of DSUs. This grant was made in lieu of cash fees, based on the September 30, 2026 closing price of $17.72 per share of common stock of Viatris Inc. (Viatris). Each DSU is fully vested and represents the right to receive one share of common stock of Viatris. The DSUs settle in shares of common stock upon the earliest of the reporting person's termination of service as a non-employee director, the reporting person's death or disability, or a change in control. |
| (2) | Represents dividend equivalent DSUs that accrued with respect to DSUs previously granted to the reporting person with respect to the election to receive payment of quarterly director fees in the form of DSUs and vest on the same schedule as the underlying DSUs. Amount represents dividend equivalent DSUs that accrued with respect to such DSUs in transactions exempt from Section 16 under Rule 16a-11. |